The strategy for enhancing temozolomide against malignant glioma

A combined therapy of the alkylating agent temozolomide (TMZ) and radiotherapy is standard treatment, and it improves the survival of patients with newly diagnosed glioblastoma (GBM). The DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT) removes the most cytotoxic lesions generated b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakada, Mitsutoshi, Furuta, Takuya, Hayashi, Yutaka, Minamoto, Toshinari, Hamada, Jun-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418701/
https://www.ncbi.nlm.nih.gov/pubmed/22912934
http://dx.doi.org/10.3389/fonc.2012.00098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418701/
https://www.ncbi.nlm.nih.gov/pubmed/22912934
http://dx.doi.org/10.3389/fonc.2012.00098

Ejemplares similares